Haloperidol

Hazard statements (CLP)

H301, H315, H317, H319, H335, H361

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 3) H301: Toxic if swallowed Skin irritation, (Category 2) H315: Causes skin irritation Eye irritation, (Category 2) H319: Causes serious eye irritation Skin sensitisation, (Category H317: May cause an allergic skin reaction Reproductive toxicity, (Category H361: Suspected of damaging fertility or the unborn child Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3), Respiratory system

Signal word

Danger

Hazard statements

H301 Toxic if swallowed. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H361 Suspected of damaging fertility or the unborn child.

Precautionary statements

P201 Obtain special instructions before use. P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell.

Supplemental label elements

none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Acute toxicity, (Category 3) H301: Toxic if swallowed. Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Skin sensitisation, (Category 1) H317: May cause an allergic skin reaction. Reproductive toxicity, (Category H361: Suspected of damaging fertility or 2) the unborn child. Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3),